Ciclosporin to Protect Renal Function In Cardiac Surgery: CiPRICS A Phase II Double Blind Randomized Placebo Controlled Study

Trial Profile

Ciclosporin to Protect Renal Function In Cardiac Surgery: CiPRICS A Phase II Double Blind Randomized Placebo Controlled Study

Completed
Phase of Trial: Phase II

Latest Information Update: 20 Oct 2016

At a glance

  • Drugs Ciclosporin (Primary)
  • Indications Acute kidney injury
  • Focus Proof of concept; Therapeutic Use
  • Acronyms CiPRICS
  • Most Recent Events

    • 13 Oct 2016 According to NeuroVive Pharmaceutical media release, the company has announced results from the exploratory phase II CiPRICS trial.
    • 07 Sep 2016 According to NeuroVive media release, data from this trial will be presented at the Rodman & Renshaw 18th Annual Global Investment Conference.
    • 30 Aug 2016 According to NeuroVive media release, an oral presentation of this trial will be presented at the Swedish Thorax meeting in October, 2016. Data collection and an initial results analysis is estimated to be completed at this time point.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top